This Solicitation opportunity from Department Of Defense was posted on July 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ERYTHROMYCIN OPHTHALMI
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Erythromycin Ophthalmic Ointment, USP, is a sterile topical medication containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use as an RX-only product. Each unit is packaged in single-dose tubes containing 3.5 grams of ointment, with a unit of issue consisting of 24 tubes per package. The product has a total shelf life of 36 months, and upon receipt by the first government activity, it must have a minimum of 31 months of remaining shelf life. Storage requirements specify controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and commercial packaging must comply with ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements. The manufacturer is PADAGIS US LLC with NDC 00574-4024-39, and the NSN is 6505-01-189-7090. The contract requires delivery of one package (24 tubes) to Fort Bragg, North Carolina, within 20 days of issuance, with FOB destination and zero tolerance for quantity variance. Delivery must be made via traceable freight methods, excluding parcel post, and packaging must meet all DLA procurement standards including palletization and hazardous material handling per FED-STD-313 where applicable. The item falls under a Type I (Code Q) shelf-life category with a non-extendable 36-month lifespan. The contracting official must submit a referral via EBS to confirm product compliance with FDA regulations, including manufacturer and part number details. The solicitation, issued under SPE2DP-26-T-4260, was posted on July 23, 2026, with a response deadline of July 29, 2026, and the required delivery date is July 14, 2026. All documentation, labeling, and marking must align with DLA’s current technical and quality requirements, and the point of contact for inquiries is James McCullough.
General Info
Agency
NAICS
Place of Performance
5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
ERYTHROMYCIN OPHTHALMIC OINTMENT,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY, STERILE
.
ROUTE: OPHTHALMIC
DOSE FORM: OINTMENT (GRAM)
STRENGTH: 5 MG/GRAM (0.5 %)
.
EACH GRAM CONTAINS ERYTHROMYCIN USP 5 MG IN A STERILE OPHTHALMIC BASE OF
MINERAL OIL AND WHITE PETROLATUM.
SPE2DP-26-T-4260
SECTION B
.
CONSISTS OF SINGLE DOSE TUBES WITH AN OPHTHALMIC TIP
.
TUBE VOLUME: 3.5 GRAMS
.
UNIT OF ISSUE IS A PACKAGE CONTAINING 24 EACH (TUBES).
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT CONTROLLED ROOM TEMPERATURE 15°30°C (59°-86°F)
.
AVOID EXCESSIVE HEAT AND PROTECT FROM FREEZING.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
1/28/2016
.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
1 PG = 24 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
PADAGIS US LLC 9MGE4 P/N NDC00574-4024-39
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017453637 0001 PG 1.000
NSN/MATERIAL:6505011897090
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
SPE2DP-26-T-4260
SECTION B
PR: 7017453637 PRLI: 0001 CONT’D
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP61900012
RDD: 204
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/14/2026
SPE2DP-26-T-4260 NSN/Part Number: 6505-01-189-7090 Quantity: 1 PG Purchase Request: 7017453637QTY: 1 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS